0001546417-16-000213.txt : 20161103
0001546417-16-000213.hdr.sgml : 20161103
20161103215511
ACCESSION NUMBER: 0001546417-16-000213
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161101
FILED AS OF DATE: 20161103
DATE AS OF CHANGE: 20161103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bloomin' Brands, Inc.
CENTRAL INDEX KEY: 0001546417
STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-EATING PLACES [5812]
IRS NUMBER: 208023465
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1228
BUSINESS ADDRESS:
STREET 1: 2202 NORTH WEST SHORE BOULEVARD
STREET 2: SUITE 500
CITY: TAMPA
STATE: FL
ZIP: 33607
BUSINESS PHONE: 813-282-1225
MAIL ADDRESS:
STREET 1: 2202 NORTH WEST SHORE BOULEVARD
STREET 2: SUITE 500
CITY: TAMPA
STATE: FL
ZIP: 33607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SMITH ELIZABETH A
CENTRAL INDEX KEY: 0001209033
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35625
FILM NUMBER: 161973505
MAIL ADDRESS:
STREET 1: 1345 AVENUE OF THE AMERICAS
CITY: NEW YORK
STATE: NY
ZIP: 10105
4
1
wf-form4_147822449891963.xml
FORM 4
X0306
4
2016-11-01
0
0001546417
Bloomin' Brands, Inc.
BLMN
0001209033
SMITH ELIZABETH A
2202 NORTH WEST SHORE BLVD
SUITE 500
TAMPA
FL
33607
1
1
0
0
Chairman and CEO
Common Stock
2016-11-01
4
M
0
125000
6.50
A
167313
D
Common Stock
2016-11-01
4
S
0
125000
17.195
D
42313
D
Common Stock
2016-11-02
4
M
0
125000
6.50
A
167313
D
Common Stock
2016-11-02
4
S
0
125000
17.112
D
42313
D
Common Stock
2016-11-03
4
M
0
37576
6.50
A
79889
D
Common Stock
2016-11-03
4
S
0
37576
17.079
D
42313
D
Stock Option (right to buy)
6.5
2016-11-01
4
M
0
125000
6.50
D
2019-11-16
Common Stock
125000.0
3475000
D
Stock Option (right to buy)
6.5
2016-11-02
4
M
0
125000
6.50
D
2019-11-16
Common Stock
125000.0
3350000
D
Stock Option (right to buy)
6.5
2016-11-03
4
M
0
37576
6.50
D
2019-11-16
Common Stock
37576.0
3312424
D
Restricted Stock Units
0.0
Common Stock
112010.0
112010
D
Stock Option (right to buy)
17.15
2026-02-25
Common Stock
261122.0
261122
D
Stock Option (right to buy)
25.36
2025-02-26
Common Stock
220589.0
220589
D
Stock Option (right to buy)
25.32
2024-02-27
Common Stock
177940.0
177940
D
Stock Option (right to buy)
10.03
2021-07-01
Common Stock
550000.0
550000
D
Price reflected is the weighted-average sales price for the shares sold. The shares were sold in multiple transactions, and the range of sale prices for the transactions reported was $17.09 to $17.52. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or any staff member of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each separate price
Price reflected is the weighted-average sales price for the shares sold. The shares were sold in multiple transactions, and the range of sale prices for the transactions reported was $17.00 to $17.29. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or any staff member of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each separate price.
Price reflected is the weighted-average sales price for the shares sold. The shares were sold in multiple transactions, and the range of sale prices for the transactions reported was $17.00 to $17.25. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or any staff member of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each separate price.
These stock options are fully vested.
These restricted stock units, in the original grant amount of 112,010, will begin vesting in four equal annual installments on February 25, 2017.
This field is not applicable.
These stock options, in the original grant amount of 261,122, will begin vesting in four equal annual installments beginning on February 25, 2017.
These stock options, in the original grant amount of 220,589, began vesting in four equal annual installments on February 26, 2016.
These stock options, in the original grant amount of 177,940, began vesting in four equal annual installments on February 27, 2015.
/s/ Kelly Lefferts, as Attorney-in-Fact
2016-11-03